![](/img/cover-not-exists.png)
Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease
O'Donnell, Peter H., Artz, Andrew S., Undevia, Samir D., Pai, Rish K., Del Cerro, Paula, Horowitz, Sarah, Godley, Lucy A., Hart, John, Innocenti, Federico, Larson, Richard A., Odenike, Olatoyosi M., SVolume:
51
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2010.520773
Date:
December, 2010
File:
PDF, 347 KB
english, 2010